Cancer Biology & Medicine: 19 (2)

February 01, 2022; Volume 19,Issue 2

Editorial

You have access
Highlighted multi-modifications of enzymes: a novel succinylation mediated by histone acetyltransferase 1 in tumors
Xiaodong Zhang, Chunyu Hou and Guang Yang

Cancer Biology & Medicine February 2022, 19 (2) 133-135; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0533
You have access
A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer
Yuchen Guo, Yangyang Zhou and Wenxin Qin

Cancer Biology & Medicine February 2022, 19 (2) 136-139; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0520
You have access
The emerging role of long noncoding RNA RMRP in cancer development and targeted therapy
Qian Hao and Xiang Zhou

Cancer Biology & Medicine February 2022, 19 (2) 140-146; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0577

You have access
Tumorigenic bacteria in colorectal cancer: mechanisms and treatments
Sha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua Du

Cancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651
You have access
Cancer metabolism and dietary interventions
Lin Qian, Fan Zhang, Miao Yin and Qunying Lei

Cancer Biology & Medicine February 2022, 19 (2) 163-174; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0461
You have access
Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data
Yufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing Xiang

Cancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634
You have access
The advance of adjuvant treatment for triple-negative breast cancer
Jingyu Ge, Wenjia Zuo, Yiyu Chen, Zhiming Shao and Keda Yu

Cancer Biology & Medicine February 2022, 19 (2) 187-201; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0752
You have access
Updates in endocrine therapy for metastatic breast cancer
Poorni M. Manohar and Nancy E. Davidson

Cancer Biology & Medicine February 2022, 19 (2) 202-212; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0255

You have access
Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng Ding

Cancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
You have access
Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian

Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
You have access
Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women
Fenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao Xie

Cancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358

You have access
Erratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposis
Mengyuan Yang, Yingxin Zhao, Yuwei Ding, Juan Wang, Yinuo Tan, Dong Xu and Ying Yuan

Cancer Biology & Medicine February 2022, 19 (2) 263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.1213